Items by Watson, Malcolm
|Up a level|
El-Bassossy, H. M., El-Fawal, R., Fahmy, A. and Watson, M. L., 2013. Arginase inhibition alleviates hypertension in the metabolic syndrome. British Journal of Pharmacology, 169 (3), pp. 693-703.
Pauling, J. D., Shipley, J. A., Raper, S., Watson, M. L., Ward, S. G., Harris, N. D. and McHugh, N. J., 2012. Comparison of infrared thermography and laser speckle contrast imaging for the dynamic assessment of digital microvascular function. Microvascular Research, 83 (2), pp. 162-167.
Korniejewska, A., McKnight, A. J., Johnson, Z., Watson, M. L. and Ward, S. G., 2011. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology, 132 (4), pp. 503-515.
Korniejewska, A., Watson, M. L. and Ward, S. G., 2010. Analysis of CXCR3 and atypical variant expression and signalling in human T lymphocytes. In: Marelli-Berg, F. M. and Nourshargh, S., eds. T-Cell Trafficking. Vol. 606. Humana Press, pp. 125-147. (Methods in Molecular Biology)
El-Bassossy, H. M., El-Maraghy, N. N., El-Fayoumi, H. M. and Watson, M. L., 2009. Haem oxygenase-1 induction protects against tumour necrosis factor α impairment of endothelial-dependent relaxation in rat isolated pulmonary artery. British Journal of Pharmacology, 158 (6), pp. 1527-1535.
El-Awady, M. S. H., Smirnov, S. V. and Watson, M. L., 2009. Voltage-independent calcium channels mediate lipopolysaccharide-induced hyporeactivity to endothelin-1 in the rat aorta. American Journal of Physiology-Heart and Circulatory Physiology, 296 (5), H1408-H1415.
Farghaly, H. S. M., Blagbrough, I. S., Medina-Tato, D. A. and Watson, M. L., 2008. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110δ-dependent mechanism. Molecular Pharmacology, 73 (5), pp. 1530-1537.
El-Awady, M. S. H., Smirnov, S. V. and Watson, M. L., 2008. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta. British Journal of Pharmacology, 155 (8), pp. 1164-1173.
El-Awady, M. S. H., Smirnov, S. V. and Watson, M. L., 2008. Lipopolysaccharide-induced vascular hypocontractility to endothelin-1 in rats is dependent on non-voltage-gated calcium channels but not on calcium sensitization. Fundamental & Clinical Pharmacology, 22 (Suppl 2), p. 74.
Farghaly, H., Causton, B., Blagbrough, I. and Watson, M. L., 2008. The effect of PI3K inhibition on IL-13-induced arginase I expression in mice tracheal segments. Fundamental & Clinical Pharmacology, 22, p. 14.
Medina-Tato, D. A., Ward, S. G. and Watson, M. L., 2007. Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology, 121, pp. 448-461.
Medina-Tato, D. A., Ward, S. G. and Watson, M. L., 2006. Cross-regulation between class IA phosphatidyl inositol 3-kinase p110 beta and p110 delta isoforms. Inflammation Research, 55 (Suppl 2), S124-S124.
Korniejewska, A., Watson, M. L. and Ward, S. G., 2006. Exploring the role for protein arginine methylation in chemokine signalling and migration of human T-lymphocytes. In: Gordon Research Conference on Chemotactic Cytokines, 2006-09-17 - 2006-09-22, Aussois.
El-Bassossy, H., El-Maraghi, N., El-Fayomi, H. and Watson, M. L., 2006. Heme oxygenase-1 protects against tumour necrosis factor-? and interleukin-1? induced hyporesponsiveness to ach in the rat pulmonary artery. In: British Pharmacological Society 75th Anniversery Meeting, 2006-12-01, Oxford.
Medina-Tato, D. A., Watson, M. L. and Ward, S. G., 2006. Leukocyte navigation mechanisms as targets in airway diseases. Drug Discovery Today, 11 (19-20), pp. 866-879.
El-Awady, M. S., Smirnov, S. V. and Watson, M. L., 2006. Mechanisms of LPS-induced changes in vascular reactivity to endothelin 1 in rat aortic and pulmonary vessels. pA2Online, 4 (2), 020P.
Patel, K. M., Wright, K. L., Whittaker, P., Chakravarty, P., Watson, M. L. and Ward, S. G., 2005. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPARγ agonists: evidence for disparate functional effects which are independent of NF-κB and PPARγ. Drug Discovery Today, 17, pp. 1098-1110.
Patel, K. M., Watson, M. L. and Ward, S. G., 2005. Differential sensitivity of class II phosphoinositide 3-kinase (PI3K) isoforms to broad spectrum P13K inhibitors. Pa2 Online, 2, 76P.
Patel, K. M., Whittaker, P., Watson, M. L. and Ward, S. G., 2003. Disparate effects of PPAR g ligands on PI3K and MAPK signalling pathways. Inflammation Research, Supplement 2, S174.
Reidy, V. A., Watson, M. L. and Woodward, B., 2002. The differing role of hemin-induced HO-1 in ischaemia-reperfusion under conditions of constant fow and constant pressure in the rat heart. Pharmacologist, 44, A18.
Reidy, V., Watson, M. L. and Woodward, B., 2002. The effect of HO-1 induction on the post-ischaemic recovery of the isolated rat heart. British Journal of Pharmacology, 135, 140P.
Williams, S., Ward, S. G. and Watson, M. L., 2002. The regulation of cyclooxygenase in tracheal epithelial cell lines. Pediatric Pulmonology, 231, S22.
Lavelle, M. J., Smith, A. W., Ward, S. G. and Watson, M. L., 2001. Phosphoinositide 3-kinase and PTEN activity in airway epithelial cells. Pediatric Pulmonology, S22, pp. 196-197.